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Maurocalcine (MCa) is a 33 amino 
acid residue peptide toxin isolated from the 
scorpion Scorpio maurus palmatus. External 
application of MCa to cultured myotubes is 
known to produce Ca2+ release from 
intracellular stores. MCa binds directly to 
the skeletal muscle isoform of the ryanodine 
receptor, an intracellular channel target of 
the endoplasmic reticulum, and induces long-
lasting channel openings in a mode of 
smaller conductance. Here, we investigated 
the way MCa proceeds to cross biological 
membranes in order to reach its target. A 
biotinylated derivative of MCa was produced 
(MCab) and complexed with a fluorescent 
indicator (streptavidine-cyanine 3) in order 
to follow the cell penetration of the toxin. 
The toxin complex efficiently penetrated in 
various cell types without requiring 
metabolic energy (low temperature) or 
implicating an endocytosis mechanism. MCa 
appeared to share the same features as the 
so-called Cell-Penetrating Peptides (CPP). 
Our results provide evidence that MCa has 
the ability to act as a molecular carrier and 
to cross cell membranes in a rapid manner 
(1-2 min) making this toxin the first 
demonstrated example of a scorpion toxin 
that translocates into cells. 
 
Maurocalcine (MCa) is a 33-mer toxin 
isolated from the venom of the scorpion Scorpio 
maurus palmatus. Since its initial isolation (1), 
MCa was successfully produced by chemical 
synthesis which allowed the characterization of 
its biological activity and the solution of its 3-D 
structure (2). MCa was shown to be one of the 
most potent effectors of the skeletal muscle 
ryanodine receptor type 1 (RyR1), an 
intracellular calcium channel target. The toxin 
stimulates the binding of [3H]-ryanodine onto 
RyR1 present in sarcoplasmic reticulum (SR) 
vesicles (3,4). It induces strong modifications in 
the gating of RyR1 channels reconstituted in 
lipid bilayers that are characterized by the 
appearance of long-lasting sub-conductance 
states (4,5). MCa application to purified SR 
vesicles produces Ca2+ release which is 
consistent with these biophysical effects (3,4). 
Using a calcium imaging approach, it was also 
shown that the addition of MCa to the 
extracellular medium of cultured myotubes 
induces Ca2+ release from the SR into the 
cytoplasm (4). Taken together, these data are 
coherent with a direct effect of MCa on RyR1. 
These observations were confirmed with the 
identification of MCa’s binding site on RyR1 
which indicates a cytoplasmic localization (6). 
According to the [1H]-NMR analysis of 
MCa, the peptide presents three disulfide bridges 
(Cys3-Cys17, Cys10-Cys21, and Cys16-Cys32) and 
folds along an Inhibitor Cystine Knot (ICK) 
motif (2). MCa contains three β-strands: from 
amino acid residues 9-11 (strand 1), 20-23 
(strand 2) and 30-33 (strand 3), respectively. The 
β-strands 2 and 3 form an antiparallel β-sheet. It 
is a highly basic peptide that contains eleven 
basic amino acid residues (33% of the molecule 
composition). Interestingly enough, eight of the 
eleven basic residues are oriented towards the 
same face of the molecule (Fig. 1A). 
Two pieces of evidence suggest that MCa 
should be able to cross the plasma membrane to 
reach its intracellular target. First, MCa has 
biological activity consistent with the direct 
activation of RyR1 when added to the 
extracellular medium. Second, a structural 
analysis of MCa reveals a stretch of positively 
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charged amino acid residues that is reminiscent 
of the protein transduction domains (PTD) found 
in proteins like Tat from the HIV-1 virus (7,8), 
the Drosophila homeotic transcription factor 
ANTP (encoded by the antennapedia gene) (9), 
and the herpes simplex virus type 1 (HSV-1) 
VP22 transcription vector (10). Synthetic 
peptides corresponding to these domains are 
called cell-penetrating peptides (CPP) and have 
in common to contain many basic residues 
(arginine and lysine), often oriented towards the 
same face of the molecule (Fig. 1B). Because of 
this structural feature, CPP possess the 
interesting ability to cross biological membranes 
in a receptor- or transporter-independent manner 
(11-13). These peptides seem to target the lipid 
bilayer directly using complementary charges 
and penetrate the cell through a mechanism 
called translocation which remains unclear. 
Three possible models have been put forth in the 
literature to explain peptide penetration: 1) the 
inverted-mycelle model (14) with its membrane-
destabilization model variant (11), 2) the carpet 
model (15), and the pore-formation model (16). 
Regardless of the precise mode of entry, CPP 
possess unique features worth mentioning: i) 
delivery in 100% of the cells (17), ii) delivery in 
all cell types both in vitro and in vivo (18,19), 
iii) ability to cross the blood-brain barrier (18), 
and iv) the possibility to act as carriers and to 
translocate large compounds, such as proteins 
and oligonucleotides (20). 
The current study was meant to investigate 
the ability of MCa to penetrate into cells. We 
show that a biotinylated version of MCa 
effectively and rapidly enters various cell types 
and can behave as a good carrier to allow the 
penetration of larger compounds. As for other 
CPP, the mechanism of cell penetration is not 
linked to an endocytotic pathway. We conclude 
that MCa represents a new class of disulfide-
linked CPP and is the first scorpion toxin shown 
to enter cells. 
 
Materials and Methods 
 
Chemical Synthesis of MCa and biotinylated 
MCa - N-α-Fmoc-L-amino acids, 4-
hydroxymethylphenyloxy resin, and reagents 
used for peptide synthesis were obtained from 
Perkin Elmer Life Sciences. N-α-Fmoc-L-
Lys(Biotin)-OH was purchased from Neosytem 
Groupe SNPE. The MCa and biotinylated MCa 
(MCab) were obtained by the solid-phase peptide 
synthesis (21) using an automated peptide 
synthesizer (Model 433A, Applied Biosystems 
Inc.). Peptide chains were assembled stepwise 
on 0.25 meq of hydroxymethylphenyloxy resin 
(1% cross-linked; 0.89 meq of amino group/g) 
using 1 mmol of N-α-Fmoc amino acid 
derivatives. The side-chain protecting groups 
were as follows: trityl for Cys and Asn; tert-
butyl for Ser, Thr, Glu, and Asp; 
pentamethylchroman for Arg; and tert-
butyloxycarbonyl or Biotin for Lys. N-α-Amino 
groups were deprotected by treatment with 18 
and 20% (v/v) piperidine/N-methylpyrrolidone 
for 3 and 8 min, respectively. The Fmoc-amino 
acid derivatives were coupled (20 min) as their 
hydroxybenzotriazole active esters in N-
methylpyrrolidone (4-fold excess). To obtain 
MCa, aliquot of peptide resin was removed at its 
corresponding cycle. After peptide chain 
assembly, the peptide resin (approximately 0.9 
g) was treated between 2 and 3 hrs at room 
temperature in constant shaking with a mixture 
of trifluoroacetic acid/ H2O/ thioanisol/ 
ethanedithiol (88: 5/5/2, v/v) in the presence of 
crystalline phenol (2.25 g). The peptide mixture 
was then filtered, and the filtrate was 
precipitated by adding cold t-butylmethyl ether. 
The crude peptide was pelleted by centrifugation 
(3.000 g for 10 min), and the supernatant was 
discarded. The reduced peptide was then 
dissolved in 200 mM Tris-HCl buffer, pH 8.3, at 
a final concentration of 2.5 mM and stirred 
under air to allow oxidation/folding (between 50 
and 72 h, room temperature). The target 
products, MCa and MCab, were purified to 
homogeneity, first by reversed-phase high 
pressure liquid chromatography (Perkin Elmer 
Life Sciences, C18 Aquapore ODS, 20 µm, 250 
x 10 mm) by means of a 60-min linear gradient 
of 0.08% (v/v) trifluoroacetic acid / 0–30% 
acetonitrile in 0.1% (v/v) trifluoroacetic 
acid/H2O at a flow rate of 6 ml/min (λ = 230 
nm). A second step of purification of MCa and 
MCab was achieved by ion-exchange 
chromatography on a carboxymethyl cellulose 
matrix using 10 mM (buffer A) and 500 mM 
(buffer B) sodium phosphate buffers, pH 9.0 
(60-min linear gradient from 0 to 60% buffer B 
at a flow rate of 1 ml/min). The homogeneity 
and identity of MCa or MCab were assessed by 
the following: (i) analytical C18 reversed-phase 
high pressure liquid chromatography (Merck, 
C18 Li-Chrospher, 5 µm, 4 x 200 mm) using a 
60-min linear gradient of 0.08% (v/v) 
trifluoroacetic acid/0–60% acetonitrile in 0.1% 
(v/v) trifluoroacetic acid/H2O at a flow rate of 1 
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ml/min; (ii) amino acid analysis after acidolysis 
(6 N HCl/2% (w/v) phenol, 20 h, 118°C, N2 
atmosphere); and (iii) mass determination by 
matrix-assisted laser desorption ionization time-
of-flight mass spectrometry.  
Formation of the MCab-streptavidin-cyanine 3 
complex - Soluble streptavidin-cyanine 3 
(Strept-Cy3, Amersham) was mixed with four 
molar equivalent of MCab (1 mM) for 2 hrs at 
room temperature in phosphate buffered saline 
(PBS). 
Preparation of heavy SR vesicles - Heavy SR 
vesicles were prepared following a modified 
method of Kim and collaborators (22) as 
described previously (23). Protein concentration 
was measured by the Biuret method.  
Cell cultures- L6 cells - Rat myogenic L6 cells 
were obtained from the European Collection of 
Animal Cell Cultures ECACC (clone C5) and 
cultured in Dulbecco’s modified Eagle’s 
medium supplemented with 15% foetal bovine 
serum (Life technologies, Inc.) and 1% penicillin 
/ streptomycin (Invitrogen). Differentiation of 
L6 cells was induced by a shift to differentiation 
medium (DMEM + 5% Horse serum) when they 
reached confluence, as described previously 
(24). 
CA1 hippocampal neurons - Hippocampuses 
from neonatal mice (between days 1 and 2 post 
partum) were dissected, cleaned of meninges 
and placed in Hanks balanced salt solution 
(HBSS; Invitrogen). They were transferred into 
a dissociation medium containing HBSS, 1% 
penicillin/streptomycin (Gibco), 2000 units/ml 
DNase I and 1% (w/v) trypsin/EDTA and 
incubated at 37°C for 7 min. After 
sedimentation, the supernatant was removed and 
the tissue was washed with a HBSS medium 
containing 1% penicillin/streptomycin. The 
tissue was gently triturated in HBBS medium 
containing 2000 units/ml DNase I, 10% foetal 
bovine serum and 1% penicillin/streptomycin 
with a plastic pipette until a homogeneous 
suspension was obtained. After centrifugation at 
100 g during 1 min, the cell pellet was 
resuspended in Neurobasal/B27 medium (Gibco) 
containing 0.5 mM L-glutamine and 1% 
penicillin/streptomycin. Cell cultures were 
seeded at a density of 105 cells/cm2 on culture 
dishes coated previously with 20 µg/ml poly-L-
lysine at 37°C for 2 hrs. After 2 days, 3 µM 
cytosine arabinoside was added to the cultures to 
control the proliferation of non-neuronal cells, 
and 24 hrs later half of the medium was 
replaced. The culture media were then 
subsequently changed every other day. 
HEK293 cells - Human embryonic kidney cells 
(HEK293, Gibco) were passaged by 1% trypsin 
treatment prior to confluence and maintained in 
DMEM containing 10% (v/v) foetal bovine 
serum and 1% penicillin / streptomycin 
(Invitrogen) and were placed into an incubator 
and 5% CO2. The culture medium was changed 
every other day. 
[3H]-ryanodine binding assay - Heavy SR 
vesicles (1 mg/ml) were incubated at 37°C for 
2.5 h in an assay buffer composed of 5 nM [3H]-
ryanodine, 150 mM NaCl, 2 mM EGTA, 2 mM 
Ca2+ (pCa=5), and 20 mM HEPES, pH 7.4. 100 
nM MCa or MCab / streptavidine-Cy3 were 
added prior to the addition of heavy SR vesicles. 
[3H]-ryanodine bound to heavy SR vesicles was 
measured by filtration through Whatmann GF/B 
glass filters followed by three washes with 5 ml 
of ice-cold washing buffer composed of 150 mM 
NaCl, 20 mM HEPES, pH 7.4. [3H]-ryanodine 
retained on the filters was measured by liquid 
scintillation. Non-specific binding was measured 
in the presence of 20 µM unlabeled ryanodine. 
The data are presented as the mean ± S.E.M. 
Each experiment was performed in triplicate and 
repeated at least twice. 
Ca2+ Release Measurements- Ca2+ release from 
heavy SR vesicles was measured using the Ca2+-
sensitive dye, antipyrylazo III. The absorbance 
was monitored at 710 nm by a diode array 
spectrophotometer (MOS-200 Optical System, 
Biologic, Claix, France). Heavy SR vesicles (50 
µg) were actively loaded with Ca2+ at 37°C in 2 
ml of a buffer containing 100 mM KCl, 7.5 mM 
sodium pyrophosphate, 20 mM MOPS, pH 7.0, 
supplemented with 250 µM antipyrylazo III, 1 
mM ATP/MgCl2, 5 mM phosphocreatine, and 12 
µg/ml creatine phosphokinase (25). Ca2+ loading 
was started by sequential additions of 50 and 20 
µM of CaCl2. In these loading conditions, no 
calcium-induced calcium release interferes with 
the observations. At the end of each experiment, 
Ca2+ remaining in the vesicles was determined 
by the addition of 4 µM Ca2+ ionophore A23187 
(Sigma) and the absorbance signal was 
calibrated by two consecutive additions of 20 
µM CaCl2. 
Imaging of MCab / Strept-Cy3 translocation by 
confocal microscopy - Imaging on fixed cells - 
Cell cultures were incubated with 100 nM (final 
concentration) of the MCab / Strept-Cy3 
complex in the cell culture medium in the dark 
and at room temperature unless otherwise stated 
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for 30 min or 1 hr. After three washes with PBS, 
cells were fixed at room temperature and in the 
dark by 3% paraformaldehyde during 20 min, 
washed with PBS and mounted with antifading 
(Dako) for observation with the confocal 
microscope. All conditions were compared 
under identical settings. Samples were analyzed 
by confocal laser scanning microscopy using a 
Leica TCS-SP2 operating system. Cy3 
fluorescence was excited by using the 543 nm 
line of a helium-neon laser, and the fluorescence 
emission was collected from 554 to 625 nm. 
Imaging on living cells - Living cells were 
incubated at room temperature in fresh culture 
medium on the stage of an upright compound 
microscope (Eclipse 600 FN, Nikon) equipped 
with a water immersion 40x objective 
(numerical aperture 0.8) and a confocal head 
(PCM 2000, Nikon) or with the Leica TCS-SP2 
microscop with a 100x objective under “XYZt” 
mode. MCab / Strept-Cy3 penetration kinetics 
were followed immediately after injection of 100 
nM of this complex into the culture medium. 
Cy3 fluorescence was excited with the 488 nm 
wavelength line of an argon laser. Emitted light 
was filtered by a 595 ± 35 nm filter. Images 
were acquired and analysed with the EZ2000 
software (Nikon). Relative fluorescence 
quantitative analysis was realized on the stack 
using the devoted Leica software. 
 
RESULTS 
 
Synthesis of biotinylated MCa and complex 
formation with Cy3-labeled streptavidine 
We have previously identified MCa as a 
potent activator of the skeletal muscle RyR1 
calcium channel (3,4). As RyR1 is an 
intracellular target, these observations suggested 
that MCa may modulate RyR1 by one of two 
mechanisms: (i) indirectly through binding onto 
a plasma membrane receptor (implies no cell 
penetration) or (ii) directly through binding onto 
RyR1 itself (implies cell penetration). With the 
recent identification of a RyR1 binding site for 
MCa (6) and earlier evidence that MCa alters the 
gating of purified RyR1 channels reconstituted 
in lipid bilayers, we favour the hypothesis that 
MCa can reach its intracellular target directly by 
crossing the plasma membrane. To investigate 
this question, we synthesized a biotinylated 
version of MCa (MCab) in order to create a 
fluorescent complex MCab coupled to Cy3-
labeled streptavidine (MCab / Strept-Cy3). We 
first tested whether biotinylation and complex 
formation with Strept-Cy3 does not impair the 
functional effects of MCa on RyR1. Fig. 2 
demonstrates that the MCab / Strept-Cy3 
complex retains the ability to stimulate [3H]-
ryanodine binding on SR vesicles (panel A) as 
well as to induce Ca2+ release from SR vesicles 
(panel B). The slower kinetics of Ca2+ release 
induced by the MCab / Strept-Cy3 complex as 
compared to MCa alone is indicative of a 
slightly reduced efficiency (Fig. 2B). This 
difference probably stems from a reduced 
accessibility of MCab / Strept-Cy3 to the active 
MCa binding site on RyR1 owing to the 
bulkiness of Strept-Cy3 (molecular weight of 
streptavidine of 60,000 Da compared to 4,108 
Da for MCab). However, these data indicate that 
the formation of a complex with Strept-Cy3 does 
not alter MCa structure and regulatory function 
making the MCab / Strept-Cy3 complex a valid 
fluorescent indicator to follow the ability of 
MCa to penetrate into cells. 
 
Cell penetration of MCab / Strept-Cy3 complex 
Using the MCab / Strept-Cy3 complex, we 
investigated the ability of MCa to transduce 
various cell types (Fig. 3). A primary cell culture 
of hippocampal CA1 neurons, and two cell lines, 
HEK293 and L6 cells (before and after 
differentiation), were incubated for 30 min 
(room temperature) with 100 nM of MCab 
complexed to Strept-Cy3. Cells were then fixed 
and the fluorescence observed by confocal 
microscopy. The data demonstrate that all cells 
are labelled, with a strong and uniform staining 
at the plasma membrane and the cytoplasm, 
whereas the nucleus is weakly labelled (Fig. 3). 
In contrast, cells incubated in the presence of 
100 nM non-biotinylated MCa and equivalent 
concentrations of Strept-Cy3 do not display any 
labelling demonstrating that Strept-Cy3 alone is 
not able to transduce into cells. The association 
of Strept-Cy3 with MCab is thus required for the 
fluorescent complex to enter cells, 
demonstrating the active function of MCa in this 
process. These data thus indicate that MCa not 
only acts as a CPP, but, like many other CPP, 
has the ability to cargo large molecular weight 
proteins (streptavidine is 14.6-fold larger than 
MCa). 
 
Kinetics of cell penetration by the MCab / Strept-
Cy3 complex 
To further characterize the transduction 
properties of MCa, we analyzed the time course 
of the fluorescence labelling of living non-
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differentiated L6 cells by MCab / Strept-Cy3 
complex. In order to achieve this study, we used 
time-lapse confocal microscopy in a way that 
preserves cell integrity and viability over at least 
a 1 hr period. Cell labelling is evident for 
periods of time as short as 3 min after the 
addition of 100 nM MCab / Strept-Cy3 complex 
in the extracellular medium (Fig. 4A). We 
defined three regions of interest (ROI) 
corresponding to the plasma membrane (ROI-1), 
the cytoplasm (ROI-2) and the nucleus (ROI-3). 
The positioning of the different ROI was 
facilitated by the analysis of the transmitted light 
image of the cell under observation (Fig. 4B). 
We then analyzed the evolution of the 
fluorescence intensity as a function of time in 
the different ROI with a Leica confocal 
microscope under the XYZt mode (Fig. 4C). At 
the start of application of 100 nM of the MCab / 
Strept-Cy3 complex in the bath, the fluorescence 
intensity increases in all cell compartments 
albeit with different rates. The evolution is 
fastest and greatest for the plasma membrane 
(ROI-1) and reaches a peak in 10 min. A slower, 
but nevertheless important, increase in 
fluorescence is also observed for the cytoplasmic 
compartment (ROI-2), while a much smaller, but 
above background, fluorescence increase is 
observed for the nucleus (ROI-3). The rate and 
the relative intensity at which fluorescence 
increases in each compartment is consistent with 
the direction of progression of the MCab / Strept-
Cy3 complex within the cell, i.e. from the 
extracellular space to the plasma membrane, 
from the plasma membrane to the cytoplasm, 
and then from the cytoplasm to the nucleus. Of 
note, the fluorescence signal recorded in ROI-1 
corresponds to the fluorescence associated to the 
plasma membrane plus the cytoplasmic area 
close to the membrane. Since the signal is 
normalized, it underestimates the plasma 
membrane associated fluorescence. In contrast, 
the relative fluorescence intensity of the 
cytoplasm should be more accurate. Two 
conclusions should be drawn from these data. 
First, the passage of the MCab / Strept-Cy3 
complex from the cytoplasm to the nucleus is 
very weak suggesting that this transition is far 
less favoured than the two other ones. Second, 
the fluorescence associated to cell compartments 
is far greater than the fluorescence from the bath 
demonstrating that cells act as MCa 
“concentrators”. We also followed the evolution 
of the fluorescence once the MCab / Strept-Cy3 
complex was washed out of the bath, i.e. after 12 
min of MCab / Strept-Cy3 application and 5 min 
of wash (Fig. 4C). We observed that the 
fluorescence intensity of ROI-1 decreases 
whereas that of ROI-2 increases. ROI-3 
fluorescence intensity remains constant. The 
fluorescence increase of the cytoplasmic 
compartment must thus be related to a continued 
transfer of the complex from the plasma 
membrane into the cytoplasm. This plasma 
membrane / cytoplasm transfer is probably the 
rate-limiting step in MCa entry. The decrease in 
fluorescence intensity of the plasma membrane 
must thus result both from a leakage of the 
fluorescent complex to the extracellular medium 
and from its transfer to the cytoplasm. Longer 
periods of observations were precluded by the 
appearance of an inhomogeneous distribution of 
the fluorescent dye in the cytoplasm, maybe 
linked to degradation pathways (data not 
shown). However, we conclude from these data 
that complexes of MCab / Strept-Cy3 that have 
penetrated into cells appear to stably remain 
inside the cell suggesting that MCa has a 
favoured direction of plasma membrane 
crossing. 
 
Endocytosis is not required for translocation of 
the MCab / Strept-Cy3 complex 
Several cell mechanisms are known that 
may allow the entry of MCa. Transduction 
mechanisms are postulated to be energy-
independent and do not require a specific 
receptor for translocation across the plasma 
membrane, whereas endocytosis and pinocytosis 
are energy-dependent. Although a contribution 
of an endocytotic process is possible, two 
reasons suggest that it is not the primary mode 
of entry of MCa. First, the distribution of the 
MCab / Strept-Cy3 complex in the cytoplasm is 
quite uniform. Second, the normal intracellular 
target of MCa (RyR1) requires a direct release of 
MCa into the cytoplasm which is hardly 
compatible with endocytosis. We nevertheless 
investigated the contribution of energy-
dependent processes in the entry of the MCab / 
Strept-Cy3 complex (Fig. 5). We first tested the 
effect of decreasing the temperature on the entry 
of MCab / Strept-Cy3 complex (Fig. 5B). The 
data unambiguously demonstrate that the entry 
of the complex still occurs at 4°C. At this 
temperature, the complex similarly labels the 
plasma membrane and the cytoplasm. Also, we 
tested the effect of specific inhibitors of 
pinocytosis and endocytosis. Neither 3 mM 
amiloride (Fig. 5C) nor 50 µM nystatin (Fig. 5D) 
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had any effect on the cell entry of the complex 
or its relative distribution in the plasma 
membrane and in the cytoplasm, again 
confirming that the main pathway for entry of 
MCa into cells does not involve either 
endocytosis or pinocytosis. 
 
DISCUSSION 
 
In this manuscript, we demonstrate that 
MCa has the ability to translocate into cells by 
crossing the plasma membrane. This process is 
rapid since translocation appears evident even 
for incubation times as short as 1 or 2 min. It 
reaches saturation in the plasma membrane 
around 10 min, though longer times were 
required for entry into the cytoplasm. This is 
consistent with the kinetics of entry of other CPP 
with a peak of entry of 15 min for the Tat-
p27Kip1 (26) and Tat-β-galactosidase 
complexes (18). 
In our experiments, we coupled MCab to 
streptavidine which is of significantly higher 
molecular weight than MCa itself, demonstrating 
that MCa can also carry large molecules into 
cells, like other CPP (27,28). The fact that MCab 
is so efficient with such a large cargo suggests 
that uncoupled MCa should be even more 
efficient when added to the extracellular medium 
of cells. Indeed, it was observed that Ca2+ release 
from myotubes alone occurred as fast as 3 sec 
after the addition of MCa, suggesting a much 
faster translocation in the absence of a cargo 
molecule. The demonstration that uncoupled 
MCa has an even faster kinetics of cell entry 
awaits the synthesis of a fluorescent derivative 
of MCa. Attempts to produce such a derivative 
have been unsuccessful so far. In our 
experiments, we used a concentration of MCab 
(100 nM) that is in the range for which other 
CPP demonstrate efficient translocation (usually 
between 25 to 200 nM (17). We show that 
translocation of MCa occurs at 4°C, as well as in 
the presence of inhibitors of pinocytosis and 
endocytosis, demonstrating that the process is 
energy-independent like for other CPP 
(17,29,30). Though the current mechanism of 
MCa translocation is unknown, we can only 
propose that it may occur along one the 
mechanisms suggested for other CPP. Like for 
other CPP, we found that maurocalcine has the 
ability to effectively translocate in different cell 
types suggesting that the process is insensitive to 
the nature of the biological membrane or to the 
types of receptors expressed on its surface. It is 
thought that CPP interact with the plasma 
membrane before translocation through their 
positively charged surface presumably with 
negative charges present at the extracellular 
surface of the lipid bilayer (31). Since MCa also 
possesses such a positively charged surface, one 
may assume that it interacts with the lipid 
bilayer in a manner akin to other CPP. 
Nevertheless, it should be mentioned that 
endocytosis may represent an additional 
contributing factor to MCa cell entry for longer 
periods of incubation though we did not 
investigate this question. Referencing the 
literature, we noticed that all CPP are small 
peptides. In Tat, the PTD encompasses the basic 
amino acid residues 47-57 (17,32,33), whereas 
in VP22 and ANTP, the PTD goes from residues 
267-300 (29) and 43-58 (14), respectively. 
Similarly, the putative PTD sequence of 
maurocalcine should be shorter than 33 amino 
acid residues. The sequence of MCa that triggers 
translocation is unknown. However, owing to its 
similarities with other CPP, the basic amino acid 
rich sequence is the principal suspect. One 
intriguing observation is that part of the same 
basic sequence involved in translocation also 
appears to mediate the interaction with RyR1. 
For instance, mutation of Arg24 of MCa, that 
belongs to the putative CPP sequence, results in 
a complete loss of interaction with RyR1 (4). 
Interestingly, part of the PTD of HIV-1 Tat, the 
Gly-Arg-Lys-Lys-Arg-Arg sequence, is also a 
potential nuclear localization sequence (12). In 
addition, Tat, VP22 and ANTP are all proteins 
implicated in transcriptional regulation, and the 
PTD are the domains that make contact with 
nucleic acids. This seems to indicate that PTD 
may intrinsically possess multiple functions: 
protein translocation (all CPP), protein targeting 
(Tat), and protein (MCa) or nucleic acid 
interaction (Tat, VP22 and ANTP). 
Overall, we thus have several arguments 
to believe that MCa behaves as a CPP. Like 
recognized CPP sequences: 1- MCa is a small 
peptide, 2- it is positively charged, 3- it enters 
many cell types, 4- it enters in an efficient 
manner, 5- at low concentration, 6- the 
translocation is a fast process, 7- that is energy-
independent, and 8- it can carry a cargo 
molecule. It possesses yet two other essential 
properties maybe not shared with other CPP 
which is i) its apparent capacity to enter cells 
against its concentration gradient and ii) to enter 
far more rapidly than to exit the cell. The 
reasons for these properties are unknown but we 
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tentatively assume that the membrane potential 
may work as a driving force for cell penetration 
and maintenance. Because MCa is structured by 
disulfide bridges, it should be classified as 
belonging to a new class of CPP. Also, the 
disulfide linkage of MCa, which makes it more 
rigid than other CPP, implies that the 
transduction mechanism at the basis of MCa cell 
penetration does not rely on extensive peptide 
unfolding. Owing to the growing importance of 
CPP in delivering functionally important 
molecules into cells, the identification of MCa 
will be useful to further understand the 
molecular basis of cell penetration of CPP. In 
addition, MCa may constitute a leading 
compound for the design of new and efficient 
analogues to deliver active drugs inside cells that 
would otherwise have limited or no 
bioavailability. A new CPP may be of interest 
for biotechnological and pharmaceutical 
companies.
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FOOTNOTES 
 
The abbreviations used are: CPP, Cell Penetrating Peptide; EDTA, Ethylenediaminetetraacetic acid; 
EGTA, Ethyleneglycol-bis(beta-aminoethylether)-N,N'-tetraacetic acid; MCa, Maurocalcine; MCab, 
Biotinylated maurocalcine; PBS, Phosphate Buffered Saline; PTD, Protein Transduction Domain; 
ROI, Region Of Interest; RyR1, Ryanodine Receptor type 1; SR. Sarcoplasmic Reticulum; Strept-
Cy3, Streptavidine-cyanine 3. 
 
FIGURE LEGENDS 
 
Fig. 1. 3-D solution structure of several peptides. 3-D solution structure of MCa (Protein Data Bank 
accession code, 1C6W). Basic amino acid residues present on the same face of MCa are shown 
(Lys11, Lys14, Lys19, Lys20, Lys22, Arg23, Arg24 and Lys30). Lys11 belongs to the β-strand 1, Lys20, Lys22 
and Arg23 to the β-strand 2, whereas Lys30 belongs to the β-strand 3. The 3-D solution structures of 
penetratin 1 (accession code 1KZ0), TAT proteins from HIV1 (1TIV) and equine infectious anemia 
virus (1TVT) are also shown. Lateral chains of basic amino acid residues are highlighted in blue. The 
primary structures of the peptides are also provided. The pictures are generated with SwissPDB 
viewer (Swiss-Prot, Switzerland). 
 
Fig. 2. The MCab / Strept-Cy3 complex is functionally active on RyR1. A, Stimulation of [3H]-
ryanodine binding by 100 nM MCa or MCab / Strept-Cy3 complex. Specific [3H]-ryanodine binding 
on SR vesicles was measured as described Materials and Methods. Dash represents binding in the 
absence of MCa or MCab / Strept-Cy3 complex. B, Induction of Ca2+ release from SR vesicles by 100 
nM MCa or MCab / Strept-Cy3 complex. 1 and 2 represent addition of 50 and 20 µM CaCl2 (final 
concentration), whereas 3 and 4 represent the consecutive addition of 20 µM CaCl2. A23187 was 
added at a final concentration of 4 µM. 
 
Fig. 3. MCab / Strept-Cy3 complex transduces efficiently in many different cell cultures. 3, 2 and 1 
day-old cultures of hippocampal CA1 neurons, HEK293 cells and non-differentiated L6 cells, 
respectively, were incubated for 30 min with 100 nM MCab complexed to Strept-Cy3 before fixation 
and confocal analysis. Differentiated L6 cells were treated similarly (4-days of differentiation). 
Fourfold smaller panels represent control experiments in which cells were treated with a mixture of 
100 nM non-biotinylated MCa and Strept-Cy3. 
 
Fig. 4. Kinetic of MCab / Strept-Cy3 complex transduction in non differentiated L6 cells. A, Confocal 
Cy3 fluorescence image of proliferating L6 cell at different times (3 sec, 3 min and 12 min) after 
addition of 100 nM MCab / Strept-Cy3 complex and 23 min after wash of the complex. Settings were 
such that the bath fluorescence of the complex is not visible. B, Position of the different ROI on the 
transmitted light image (differential interference contrast, top panel) and resulting position on the 
corresponding confocal Cy3 fluorescence image. C, Evolution of the Cy3 fluorescence intensity 
normalized to the unity of ROI surface in the different L6 compartments as a function of time. The 
MCab / Strept-Cy3 complex was applied at a concentration of 100 nM at t=0 min and washed for 5 
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min out of the bath after t=12 min. Basal ROI represents the fluorescence intensity of the extracellular 
solution. Data are the mean ± s.d. of n=5 different cells. Similar results were also observed in three 
different cell preparations. 
 
Fig. 5. Cell entry of the MCab / Strept-Cy3 complex is energy-independent. A, Control condition for 
the entry of MCab / Strept-Cy3 complex into HEK293 cells. Cells were incubated in the presence of 
100 nM of the complex for 1 hr at 22°C. Cells were fixed and images acquired by confocal 
microscopy. B, Effect of temperature on MCab / Strept-Cy3 complex entry. Cells were incubated and 
observed in similar experimental conditions than at 22°C. C, Effect of 50 µM nystatin on MCab / 
Strept-Cy3 complex entry into HEK293 cells. Nystatin is an inhibitor of pinocytosis. Conditions as in 
A. D, Effect of 3 mM amiloride on MCab / Strept-Cy3 complex entry into HEK293 cells. Amiloride is 
an inhibitor of caveolae endocytosis. Conditions as in A. 
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